Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Anglesio

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival HeterogeneityClara Bodelon, J Keith Killian, Joshua N Sampson, et al.
Molecular Cancer Research : MCR|November 18, 2008
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumorsMichael S Anglesio, Jeremy M Arnold, Joshy George, et al.
Nature Medicine|August 19, 2007
The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancersLiyong Zhang, Michael S Anglesio, Maureen O'Sullivan, et al.
Plos One|April 21, 2016
Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect CorrectionAline Talhouk, Stefan Kommoss, Robertson Mackenzie, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 12, 2025
M2 Macrophages are Major Mediators of Germline Risk of Endometriosis and Explain Pleiotropy With Comorbid TraitsSoledad Ochoa, Fernanda S Rasquel-Oliveira, Brett McKinnon, et al.
The Journal of Pathology. Clinical Research|March 28, 2023
KRAS mutations and endometriosis burden of diseaseNatasha L Orr, Arianne Albert, Yang Doris Liu, et al.
Cancers|December 23, 2020
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian CancerMarie Christine Wulff Westergaard, Katy Milne, Magnus Pedersen, et al.
The Journal of Pathology|February 19, 2015
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burdenMichael S Anglesio, Ali Bashashati, Yi Kan Wang, et al.
Oncotarget|October 28, 2015
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genesSally M Hunter, Michael S Anglesio, Georgina L Ryland, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival HeterogeneityClara Bodelon, J Keith Killian, Joshua N Sampson, et al.
Molecular Cancer Research : MCR|November 18, 2008
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumorsMichael S Anglesio, Jeremy M Arnold, Joshy George, et al.
Nature Medicine|August 19, 2007
The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancersLiyong Zhang, Michael S Anglesio, Maureen O'Sullivan, et al.
Plos One|April 21, 2016
Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect CorrectionAline Talhouk, Stefan Kommoss, Robertson Mackenzie, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 12, 2025
M2 Macrophages are Major Mediators of Germline Risk of Endometriosis and Explain Pleiotropy With Comorbid TraitsSoledad Ochoa, Fernanda S Rasquel-Oliveira, Brett McKinnon, et al.
The Journal of Pathology. Clinical Research|March 28, 2023
KRAS mutations and endometriosis burden of diseaseNatasha L Orr, Arianne Albert, Yang Doris Liu, et al.
Cancers|December 23, 2020
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian CancerMarie Christine Wulff Westergaard, Katy Milne, Magnus Pedersen, et al.
The Journal of Pathology|February 19, 2015
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burdenMichael S Anglesio, Ali Bashashati, Yi Kan Wang, et al.
Oncotarget|October 28, 2015
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genesSally M Hunter, Michael S Anglesio, Georgina L Ryland, et al.
Pageof 9